Sökning: onr:"swepub:oai:DiVA.org:liu-36168" >
Requirement for CDK...
-
Yu, QunyanDepartment of Cancer Biology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts
(författare)
Requirement for CDK4 kinase function in breast cancer
- Artikel/kapitelEngelska2006
Förlag, utgivningsår, omfång ...
-
Elsevier BV,2006
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:liu-36168
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-36168URI
-
https://doi.org/10.1016/j.ccr.2005.12.012DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Cyclin D1 is overexpressed in the majority of human breast cancers. We previously found that mice lacking cyclin D1 are resistant to mammary carcinomas triggered by the ErbB-2 oncogene. In this study, we investigated which function of cyclin D1 is required for ErbB-2-driven mammary oncogenesis. We report that the ability of cyclin D1 to activate cyclin-dependent kinase CDK4 underlies the critical role for cyclin D1 in breast cancer formation. We also found that the continued presence of CDK4-associated kinase activity is required to maintain breast tumorigenesis. We analyzed primary human breast cancers and found high cyclin D1 levels in a subset (∼25%) of ErbB-2-overexpressing tumors. We propose that this subset of breast cancer patients might benefit from inhibiting CDK4 kinase.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Sicinska, EwaDepartment of Cancer Biology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts
(författare)
-
Geng, YanDepartment of Cancer Biology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts
(författare)
-
Ahnström, Marie,1976-Linköpings universitet,Onkologi,Hälsouniversitetet(Swepub:liu)marah62
(författare)
-
Zagozdzon, AgnieszkaDepartment of Cancer Biology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts
(författare)
-
Kong, YinxinDepartment of Cancer Biology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts
(författare)
-
Gardner, HumphreyDepartment of Research Pathology, Biogen Idec, Cambridge, Massachusetts
(författare)
-
Kiyokawa, HiroakiDepartment of Molecular Pharmacology and Biochemical Chemistry, Northwestern University, Chicago, Illinois
(författare)
-
Harris, Lyndsay NDepartment of Cancer Biology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts and Department of Medical Oncology, Dana-Farber Cancer Institute, and Brigham and Women's Hospital, Boston, Massachusetts
(författare)
-
Stål, Olle,1952-Linköpings universitet,Onkologi,Hälsouniversitetet(Swepub:liu)ollst87
(författare)
-
Sicinski, PiotrDepartment of Cancer Biology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts
(författare)
-
Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, MassachusettsOnkologi
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Cancer Cell: Elsevier BV9:1, s. 23-321535-61081878-3686
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Yu, Qunyan
-
Sicinska, Ewa
-
Geng, Yan
-
Ahnström, Marie, ...
-
Zagozdzon, Agnie ...
-
Kong, Yinxin
-
visa fler...
-
Gardner, Humphre ...
-
Kiyokawa, Hiroak ...
-
Harris, Lyndsay ...
-
Stål, Olle, 1952 ...
-
Sicinski, Piotr
-
visa färre...
- Artiklar i publikationen
-
Cancer Cell
- Av lärosätet
-
Linköpings universitet